HRP20100471T1 - Depsipeptidi za prevenciju vertikalnih endoparazitnih infekcija - Google Patents
Depsipeptidi za prevenciju vertikalnih endoparazitnih infekcija Download PDFInfo
- Publication number
- HRP20100471T1 HRP20100471T1 HR20100471T HRP20100471T HRP20100471T1 HR P20100471 T1 HRP20100471 T1 HR P20100471T1 HR 20100471 T HR20100471 T HR 20100471T HR P20100471 T HRP20100471 T HR P20100471T HR P20100471 T1 HRP20100471 T1 HR P20100471T1
- Authority
- HR
- Croatia
- Prior art keywords
- prevention
- depsipeptides
- use according
- vertical
- depsipeptide
- Prior art date
Links
- 108010002156 Depsipeptides Proteins 0.000 title claims abstract 7
- 208000015181 infectious disease Diseases 0.000 title claims abstract 4
- 230000002265 prevention Effects 0.000 title claims abstract 4
- 244000079386 endoparasite Species 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- -1 N-morpholinyl Chemical group 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 108010056417 emodepside Proteins 0.000 claims 1
- ZMQMTKVVAMWKNY-YSXLEBCMSA-N emodepside Chemical compound C([C@@H]1C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@H](C(O[C@H](CC=2C=CC(=CC=2)N2CCOCC2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O1)=O)CC(C)C)C(C=C1)=CC=C1N1CCOCC1 ZMQMTKVVAMWKNY-YSXLEBCMSA-N 0.000 claims 1
- 229960001575 emodepside Drugs 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Abstract
Uporaba endoparaziticidnih depsipeptida, naznačena time, da služi za proizvodnju farmaceutskih pripravaka za prevenciju vertikalnih endoparazitnih infekcija. Patent sadrži još 5 patentnih zahtjeva.
Claims (6)
1. Uporaba endoparaziticidnih depsipeptida, naznačena time, da služi za proizvodnju farmaceutskih pripravaka za prevenciju vertikalnih endoparazitnih infekcija.
2. Uporaba u skladu sa zahtjevom 1, naznačena time, da se koristi ciklički depsipeptid koji ima 24 atoma u prstenu.
3. Uporaba u skladu sa zahtjevom 2, naznačena time, da se koristi depsipeptid koji je spoj PF 1022 formule (IIa):
[image]
Ili je spoj formule (IIb):
[image]
u kojoj
Z je N-morfolinil, amino, mono- ili dimetilamino.
4. Uporaba u skladu sa zahtjevom 3, naznačena time, da endoparaziticidni depsipeptid koji se koristi je emodepsid.
5. Uporaba u skladu sa zahtjevom 3, naznačena time, da endoparaziticidni depsipeptid koji se koristi je PF 1022.
6. Uporaba u skladu sa jednim od prethodnih zahtjeva, naznačena time, da se koristi za prevenciju vertikalnih endoparazitnih infekcija kod pasa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004055316A DE102004055316A1 (de) | 2004-11-16 | 2004-11-16 | Verhinderung vertikaler Endoparasiten-Infektionen |
| PCT/EP2005/011748 WO2006053641A1 (de) | 2004-11-16 | 2005-11-03 | Verhinderung vertikaler endoparasiten-infektionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100471T1 true HRP20100471T1 (hr) | 2010-10-31 |
Family
ID=35767587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100471T HRP20100471T1 (hr) | 2004-11-16 | 2010-08-30 | Depsipeptidi za prevenciju vertikalnih endoparazitnih infekcija |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20090215678A1 (hr) |
| EP (1) | EP1814572B1 (hr) |
| JP (1) | JP5078619B2 (hr) |
| KR (1) | KR101280511B1 (hr) |
| CN (1) | CN101102785B (hr) |
| AR (1) | AR052133A1 (hr) |
| AT (1) | ATE469652T1 (hr) |
| AU (1) | AU2005306070B2 (hr) |
| BR (1) | BRPI0518172A (hr) |
| CA (1) | CA2587537C (hr) |
| CR (1) | CR9108A (hr) |
| DE (2) | DE102004055316A1 (hr) |
| DK (1) | DK1814572T3 (hr) |
| ES (1) | ES2345265T3 (hr) |
| HK (1) | HK1117041A1 (hr) |
| HR (1) | HRP20100471T1 (hr) |
| IL (1) | IL183200A (hr) |
| MX (1) | MX2007005766A (hr) |
| MY (1) | MY142727A (hr) |
| NO (1) | NO341472B1 (hr) |
| NZ (1) | NZ555117A (hr) |
| PE (1) | PE20061079A1 (hr) |
| PL (1) | PL1814572T3 (hr) |
| PT (1) | PT1814572E (hr) |
| RU (1) | RU2405565C2 (hr) |
| SI (1) | SI1814572T1 (hr) |
| TW (1) | TWI358293B (hr) |
| UA (1) | UA91694C2 (hr) |
| WO (1) | WO2006053641A1 (hr) |
| ZA (1) | ZA200703982B (hr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008022520A1 (de) * | 2008-05-07 | 2009-11-12 | Bayer Animal Health Gmbh | Feste Arzneimittelformulierung mit verzögerter Freisetzung |
| CN104023710A (zh) * | 2011-12-21 | 2014-09-03 | 拜耳知识产权有限责任公司 | 包含无定形艾默德斯的制剂 |
| MX2021001566A (es) | 2015-05-20 | 2022-09-12 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos depsipeptidicos como anthelminticos. |
| JP6943859B2 (ja) | 2015-12-28 | 2021-10-06 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 駆虫性デプシペプチド化合物 |
| US11382949B2 (en) | 2016-11-16 | 2022-07-12 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic depsipeptide compounds |
| CN111757880A (zh) | 2017-11-07 | 2020-10-09 | 拜耳动物保健有限责任公司 | 用于合成环状缩肽的方法 |
| EP3480195A1 (en) | 2017-11-07 | 2019-05-08 | Bayer Animal Health GmbH | Method for the synthesis of cyclic depsipeptides |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2362539C2 (de) * | 1973-12-17 | 1986-05-07 | Merck Patent Gmbh, 6100 Darmstadt | 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| NO176766C (no) * | 1989-02-07 | 1995-05-24 | Meiji Seika Kaisha | Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet |
| DE122005000058I1 (de) * | 1992-03-17 | 2006-04-27 | Astellas Pharma Inc | Depsipeptide, Herstellung und Anwendung |
| DE4317458A1 (de) * | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
| CA2155871A1 (en) * | 1993-02-19 | 1994-09-01 | Makoto Ohyama | Derivatives of cyclodepsipeptide pf 1022 |
| ATE143601T1 (de) * | 1993-05-05 | 1996-10-15 | Palo Alto Medical Found | Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose |
| DE4317457A1 (de) * | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
| DE4317432A1 (de) * | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
| EP0718293B1 (en) * | 1993-09-06 | 2002-03-13 | Fujisawa Pharmaceutical Co., Ltd. | Cyclodepsipeptide compound |
| DE4400464A1 (de) * | 1994-01-11 | 1995-07-13 | Bayer Ag | Endoparasitizide Mittel |
| DE4401389A1 (de) * | 1994-01-19 | 1995-07-20 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung |
| DE4406025A1 (de) * | 1994-02-24 | 1995-08-31 | Bayer Ag | Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung |
| DE4437198A1 (de) * | 1994-10-18 | 1996-04-25 | Bayer Ag | Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden |
| CN1162409C (zh) * | 1995-06-30 | 2004-08-18 | 藤泽药品工业株式会社 | 缩肽衍生物、其新型中间体以及中间体的制造方法 |
| WO1997011064A1 (fr) * | 1995-09-22 | 1997-03-27 | Meiji Seika Kaisha, Ltd. | Nouveaux derives depsipeptides cycliques de pf1022 |
| DE19545639A1 (de) * | 1995-12-07 | 1997-06-12 | Bayer Ag | Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen |
| DE19962147A1 (de) * | 1999-12-22 | 2001-06-28 | Bayer Ag | Schädlingsbekämpfungsmittel / PF 1022-221 |
| US20010036922A1 (en) * | 2000-04-03 | 2001-11-01 | Benchaoui Hafid Abdelaali | Method of treating a parasitic infection |
| GB0008353D0 (en) * | 2000-04-03 | 2000-05-24 | Pfizer Ltd | Method of treating a parasitic infection |
| DE10358525A1 (de) * | 2003-12-13 | 2005-07-07 | Bayer Healthcare Ag | Endoparasitizide Mittel zur topischen Applikation |
| DE102005011779A1 (de) * | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
-
2004
- 2004-11-16 DE DE102004055316A patent/DE102004055316A1/de not_active Withdrawn
-
2005
- 2005-11-03 PT PT05800013T patent/PT1814572E/pt unknown
- 2005-11-03 KR KR1020077011479A patent/KR101280511B1/ko active IP Right Grant
- 2005-11-03 CN CN2005800466551A patent/CN101102785B/zh active Active
- 2005-11-03 AU AU2005306070A patent/AU2005306070B2/en active Active
- 2005-11-03 BR BRPI0518172-0A patent/BRPI0518172A/pt not_active Application Discontinuation
- 2005-11-03 NZ NZ555117A patent/NZ555117A/en unknown
- 2005-11-03 AT AT05800013T patent/ATE469652T1/de active
- 2005-11-03 DE DE502005009697T patent/DE502005009697D1/de active Active
- 2005-11-03 PL PL05800013T patent/PL1814572T3/pl unknown
- 2005-11-03 EP EP05800013A patent/EP1814572B1/de active Active
- 2005-11-03 MX MX2007005766A patent/MX2007005766A/es active IP Right Grant
- 2005-11-03 WO PCT/EP2005/011748 patent/WO2006053641A1/de active Application Filing
- 2005-11-03 SI SI200531078T patent/SI1814572T1/sl unknown
- 2005-11-03 DK DK05800013.4T patent/DK1814572T3/da active
- 2005-11-03 US US11/719,379 patent/US20090215678A1/en not_active Abandoned
- 2005-11-03 CA CA2587537A patent/CA2587537C/en active Active
- 2005-11-03 RU RU2007122284/15A patent/RU2405565C2/ru active
- 2005-11-03 JP JP2007541733A patent/JP5078619B2/ja active Active
- 2005-11-03 UA UAA200706853A patent/UA91694C2/ru unknown
- 2005-11-03 ES ES05800013T patent/ES2345265T3/es active Active
- 2005-11-15 TW TW094140003A patent/TWI358293B/zh active
- 2005-11-15 MY MYPI20055348A patent/MY142727A/en unknown
- 2005-11-15 PE PE2005001335A patent/PE20061079A1/es not_active Application Discontinuation
- 2005-11-15 AR ARP050104792A patent/AR052133A1/es not_active Application Discontinuation
-
2007
- 2007-05-09 CR CR9108A patent/CR9108A/es unknown
- 2007-05-15 IL IL183200A patent/IL183200A/en active IP Right Grant
- 2007-05-16 ZA ZA200703982A patent/ZA200703982B/xx unknown
- 2007-06-13 NO NO20073023A patent/NO341472B1/no unknown
-
2008
- 2008-07-03 HK HK08107354.7A patent/HK1117041A1/xx unknown
-
2010
- 2010-08-30 HR HR20100471T patent/HRP20100471T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100471T1 (hr) | Depsipeptidi za prevenciju vertikalnih endoparazitnih infekcija | |
| HUP0303271A2 (hu) | Rapamycin felhasználása rák kezelésére alkalmas gyógyszerkészítmény elõállítására | |
| BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
| RS20090249A (en) | Spiroketone acetyl-coa carboxylase inhibotors | |
| AR107864A1 (es) | ÁCIDO 7a,11b-DIHIDROXI-6a-ETIL-5b-COLAN-24-OICO Y COMPOSICIONES FARMACÉUTICAS | |
| BRPI0508966A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| EA200702497A1 (ru) | Замещенные арилпиразолы для применения против паразитов | |
| MD3507289T2 (ro) | Modulatori alosterici pozitivi ai receptorilor muscarinici M1 | |
| GEP20156209B (en) | Linaclotide-containing formulations for oral administration | |
| AR041370A1 (es) | Formulaciones farmaceuticas solidas que comprenden telmisartano y su preparacion | |
| ES2340502T3 (es) | Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad. | |
| EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
| BRPI0615898B8 (pt) | composição farmacêutica, e, uso de um composto ou de um sal, um solvato, um hidrato ou uma forma morfológica do mesmo farmaceuticamente aceitável | |
| HK1076605A1 (en) | Formulations | |
| CY1105559T1 (el) | Φαρμακευτικες συνθεσεις του tegaserod | |
| ATE254630T1 (de) | Cyclosporine | |
| RS54258B1 (en) | SRC / ABL INHIBITOR FORMULATIONS | |
| AR029226A1 (es) | Tioamidas, composiciones farmaceuticas y el uso de la misma para la fabricacion de compuestos medicinales | |
| EA201201414A8 (ru) | КОМБИНАЦИИ, СОДЕРЖАЩИЕ ЗАМЕЩЕННЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНЫ | |
| TW200517106A (en) | Sustained release pharmaceutical compositions | |
| CA2508824A1 (fr) | Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent | |
| NO20073405L (no) | Farmasoytisk utforming inneholdende en frigjoringshastighetskontrollerende sammensetning | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| NZ588428A (en) | Oral and injectable formulations of the tetracycline compound 9-[(2,2-dimethyl-propylamino)-methyl]-minocycline | |
| BR0311189A (pt) | Composições farmacêuticas contendo polimorfo a de flibanserin |